Houston medtech co. VenoStent completes $16M Series A round
As VenoStent prepares for clinical trials of its SelfWrap device, the company scored funding from both local and national investors.
Building "Bridges" Across the Bayou City!
As VenoStent prepares for clinical trials of its SelfWrap device, the company scored funding from both local and national investors.